WeVote
Log In

Bill

Bill

HB 1837

Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1 or 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.

89th Legislature (2025) Introduced by Ryan Guillen and 3 co-sponsors

Texas bill strengthens penalties for fentanyl/opioid distribution while improving officer safety protocols and expanding opioid antagonist availability.

Referred to Criminal Justice
#alcoholism&drugabuse(i0030) #border(s0045) #crimes--drugs(i0185) #governor(i0375) #health&humanservicescommission(v0177) #health--general(i0385) #interimstudies(i0448) #lawenforcement #texascommissionon(v0986) #lethalopioidpoisoningpreventiontaskforce(v262l) #lawenforcement(i0510) #peaceofficers(s0007) #publicsafety #departmentof(v0251)
0
WeVote Research Nonpartisan
Bill Summary · HB 1837

Legislative bill overview

HB 1837 addresses criminal enforcement against drug manufacturing and distribution of high-penalty controlled substances (Penalty Groups 1 and 1-B, which include fentanyl, heroin, and other opioids), while also incorporating provisions for law enforcement officer safety when handling these substances and expanding access to opioid antagonists like naloxone. The bill appears to combine stricter drug enforcement measures with public health harm-reduction tools.

Why is this important

Texas has experienced significant increases in overdose deaths, particularly from synthetic opioids like fentanyl, creating dual pressures for both criminal enforcement and emergency response capacity. The bill addresses officer safety concerns—handlers of fentanyl and similar substances face accidental exposure risks—while simultaneously recognizing that opioid antagonists are critical emergency interventions that can reverse overdoses and save lives.

Potential points of contention

  • Enforcement vs. treatment approach: Critics may argue the bill prioritizes criminalization over substance abuse treatment and prevention programs, which research suggests are more cost-effective at reducing drug use long-term
  • Officer safety vs. civil liberties: Enhanced enforcement protocols and handling procedures could lead to more aggressive policing practices or increased arrests that disproportionately affect certain communities
  • Opioid antagonist distribution scope: Disagreement may arise over how broadly antagonists should be distributed (pharmacy access, community programs, first responders only) and who bears costs, potentially limiting accessibility if implementation is restrictive

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.